Comprehensive Guide to ABH Healthcare IPO: Business Model, Financials, and Market Analysis
The highly anticipated public offering from ABH Healthcare Ltd. has caught the attention of market participants. Operating a robust medical infrastructure under the brand "Anil Baghi Hospital," the company is stepping into the primary markets to raise capital for expansion and debt reduction. In this detailed review, we will dissect the company's operational footprint, financial health, valuation metrics, and critical subscription details to help you make an informed observation of this upcoming SME IPO.
Company Overview: What Does ABH Healthcare Do?
ABH Healthcare Ltd. is a prominent regional healthcare provider operating a multi-specialty facility equipped with 150 beds. The institution delivers medical care across 25 distinct specialties, ensuring comprehensive healthcare solutions for its patients.
- Key Specialties: The hospital provides advanced treatments in cardiac sciences, neurology, minimally invasive brain and spine surgeries, medical and surgical gastroenterology, bariatric surgery, urology, pulmonology, and nephrology.
- Insurance & Government Tie-ups: Strengthening its patient acquisition channel, the hospital is empaneled with over 30 private and public health insurance providers. It actively participates in major government schemes, including ECHS, Railways, BSNL, FCI, and the Ayushman Bharat - Sarbat Sehat Bima Yojana (ABSSBY).
- Professional Workforce: The healthcare delivery is supported by a dedicated team of 37 experienced doctors and 101 nursing professionals (as of mid-2026).
ABH Healthcare IPO Critical Dates & Timeline
Timing is crucial when tracking primary market offerings. Below is the scheduled timeline from the opening of the bidding window to the final listing on the NSE SME platform.
IPO Status & Progress Tracker
| Event Category | Tentative Date |
|---|---|
| Bid Opening Date | Monday, August 24, 2026 |
| Bid Closing Date | Wednesday, August 26, 2026 |
| Finalization of Allotment | Thursday, August 27, 2026 |
| Initiation of Refunds | Friday, August 28, 2026 |
| Credit of Shares to Demat | Friday, August 28, 2026 |
| Listing Date on NSE SME | Monday, August 31, 2026 |
Core IPO Parameters and Offer Details
The public issue is a Book Built offering aimed at raising ₹34.98 Crores. The entire offering consists of fresh capital generation with no existing shares being sold by current promoters.
| Specification | Details |
|---|---|
| Issue Size | 34,29,600 Equity Shares (Aggregating up to ₹35.00 Cr) |
| Issue Structure | 100% Fresh Issue |
| Price Band | ₹96 to ₹102 per Equity Share |
| Face Value | ₹10 per Share |
| Listing Exchange | NSE SME |
| Market Maker Allocation | 1,72,800 Shares |
| Net Offer to Public | 32,56,800 Shares |
Investment Application & Lot Size Guidelines
Investors must bid in specific lot multiples as determined by the exchange. Notably, for the Retail Individual Investor category in this specific offering, the minimum application threshold has been set at 2 lots.
| Investor Profile | Minimum Lots | Total Shares | Investment Amount (at Upper Price) |
|---|---|---|---|
| Retail Investor (Min) | 2 Lots | 2,400 Shares | ₹2,44,800 |
| Retail Investor (Max) | 2 Lots | 2,400 Shares | ₹2,44,800 |
| Small HNI (Min) | 3 Lots | 3,600 Shares | ₹3,67,200 |
| Small HNI (Max) | 8 Lots | 9,600 Shares | ₹9,79,200 |
| Big HNI (Min) | 9 Lots | 10,800 Shares | ₹11,01,600 |
Financial Health and Corporate Performance
Evaluating the fundamentals is a critical step before making any market decisions. The financial records of ABH Healthcare showcase steady revenue growth and an improving bottom line over the last three fiscal periods.
| Financial Metric (₹ in Crores) | FY Ended Mar 31, 2026 | FY Ended Mar 31, 2025 | FY Ended Mar 31, 2024 |
|---|---|---|---|
| Total Assets | 85.27 | 63.90 | 51.35 |
| Total Revenue | 52.59 | 49.32 | 41.39 |
| EBITDA | 14.72 | 13.20 | 6.89 |
| Profit After Tax (PAT) | 5.64 | 5.35 | 1.66 |
| Total Borrowings | 45.75 | 33.78 | 30.59 |
| Net Worth | 17.27 | 11.60 | 6.30 |
Key Performance Indicators (KPIs) & Valuation
To gauge how the company is priced compared to its earnings and intrinsic value, we look at its fundamental valuation metrics.
| Performance Indicator | Metric Recorded (FY26) |
|---|---|
| Return on Equity (ROE) | 39.07% |
| Return on Capital Employed (ROCE) | 19.09% |
| EBITDA Margin | 28.03% |
| PAT Margin | 10.74% |
| Debt to Equity Ratio | 3.20x |
| Pre-IPO P/E Ratio | 14.47x |
| Post-IPO P/E Ratio | 20.69x |
| Estimated Market Cap | ₹116.58 Crores |
Primary Objectives of the Public Issue
Capital raised through the fresh allocation of shares will be strategically deployed across several verticals to strengthen the balance sheet and foster growth.
- Debt Restructuring: ₹17.00 Crores will be directed towards the repayment or prepayment of existing company borrowings, which will subsequently improve profit margins by reducing interest burdens.
- Working Capital: ₹5.00 Crores will be infused into everyday operations to maintain liquidity.
- Corporate Expansion & Inorganic Growth: Remaining funds are earmarked for potential unidentified acquisitions and general corporate necessities.
SWOT Analysis of ABH Healthcare
Strengths
- Diverse clinical specialties ensuring multiple revenue streams.
- Strong tie-ups with 30+ insurance providers and government healthcare schemes.
- Experienced doctor-led professional management team.
Weaknesses
- High Debt-to-Equity ratio standing at 3.20, indicating heavy reliance on borrowed capital prior to the IPO.
- Geographical concentration risk as operations are primarily centralized in the Punjab region.
Opportunities
- Deployment of IPO funds for inorganic growth and regional acquisitions.
- Reduction in finance costs post-debt repayment, directly improving future PAT margins.
Threats
- Intense competition from established corporate hospital chains entering regional markets.
- Changes in government healthcare scheme payout structures or insurance regulations.
Corporate Leadership and Promoter Holdings
The strategic direction of the healthcare facility is steered by its founding promoters: Kamal Baghi, Saurabh Baghi, and Vaishali Saini.
- Pre-Issue Shareholding: 100.00%
- Post-Issue Shareholding: 69.99%
Key Intermediaries & Contact Information
Registrar to the Issue
Bigshare Services Pvt. Ltd.
Email: ipo@bigshareonline.com
Phone: 8657578989 / 8069219065 / 8069219060
Lead Management
Fedex Securities Pvt. Ltd. serves as the sole Book Running Lead Manager for this SME offering.
Company Headquarters
ABH Healthcare Ltd.
Anil Baghi Road, Ferozepur,
Punjab - 152002
Email: investor@anilbaghihospital.com
Summary and Final Takeaway
The upcoming stock offering from ABH Healthcare presents a window into the regional healthcare sector's potential. By operating a multi-specialty 150-bed hospital with strong government and insurance affiliations, the company has demonstrated consistent revenue generation and a solid Return on Equity (ROE). The strategic move to utilize IPO proceeds for debt reduction addresses one of the company's main financial vulnerabilities—its high borrowing level. Market participants closely monitoring the SME segment should weigh the robust operational metrics against the premium post-issue valuation multiples before committing capital to the primary markets.